Trademark: 97115924
Word

Status
Registered
Status Code
700
Status Date
Tuesday, December 12, 2023
Serial Number
97115924
Registration Number
7243679
Registration Date
Tuesday, December 12, 2023
Mark Type
2000
Filing Date
Tuesday, November 9, 2021
Published for Opposition
Tuesday, October 4, 2022

Trademark Owner History
Allergan, Inc. - Original Registrant

Classifications
36 Medical advisory services regarding treatment payment plan reimbursement of a portion of a patient's out-of-pocket expenses, namely, providing financial administration of patient reimbursement programs; assistance to patients regarding treatment payment plan options, namely, financial administration of patient reimbursement programs; providing financial information about the administration of patient reimbursement programs designed to assist patients regarding medical treatment payment plan options
35 Providing business information about the administration of patient reimbursement programs designed to assist patients regarding medical treatment payment plan options; assistance to patients regarding treatment payment plan options, namely, business administration of patient reimbursement programs; providing a website via a global computer network featuring consumer information and comprehensive content being consumer product information in the fields of neurology, dermatology and urology; distribution of samples for trial purposes in the field of neurology, dermatology and urology; promoting healthcare professionals' awareness of the benefits of botulinum toxin and dissemination of advertisements and consumer product information relating to botulinum toxin via print, audio, video, digital, on-line medium, and electronic mail
The mark consists of three curved lines.
Color is not claimed as a feature of the mark.

Trademark Events
Dec 12, 2023
Notice Of Registration Confirmation Emailed
Dec 12, 2023
Registered-Principal Register
Nov 9, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Nov 8, 2023
Allowed Principal Register - Sou Accepted
Nov 8, 2023
Examiner's Amendment Entered
Nov 8, 2023
Notification Of Examiners Amendment E-Mailed
Nov 8, 2023
Examiners Amendment E-Mailed
Nov 8, 2023
Su-Examiner's Amendment Written
Nov 1, 2023
Notification Of Non-Final Action E-Mailed
Nov 1, 2023
Non-Final Action E-Mailed
Nov 1, 2023
Su - Non-Final Action - Written
May 16, 2023
Statement Of Use Processing Complete
Apr 21, 2023
Use Amendment Filed
May 10, 2023
Case Assigned To Intent To Use Paralegal
Apr 21, 2023
Teas Statement Of Use Received
Nov 29, 2022
Noa E-Mailed - Sou Required From Applicant
Oct 4, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 4, 2022
Published For Opposition
Sep 14, 2022
Notification Of Notice Of Publication E-Mailed
Sep 1, 2022
Approved For Pub - Principal Register
Aug 30, 2022
Teas/Email Correspondence Entered
Aug 29, 2022
Correspondence Received In Law Office
Aug 29, 2022
Teas Request For Reconsideration Received
Jun 7, 2022
Notification Of Final Refusal Emailed
Jun 7, 2022
Final Refusal E-Mailed
Jun 7, 2022
Final Refusal Written
May 16, 2022
Teas/Email Correspondence Entered
May 16, 2022
Correspondence Received In Law Office
May 16, 2022
Teas Response To Office Action Received
Nov 29, 2021
Notification Of Non-Final Action E-Mailed
Nov 29, 2021
Non-Final Action E-Mailed
Nov 29, 2021
Non-Final Action Written
Nov 24, 2021
Assigned To Examiner
Nov 19, 2021
Notice Of Design Search Code E-Mailed
Nov 18, 2021
New Application Office Supplied Data Entered

Trademark Alertz updated from USPTO on 2030-01-24